 |
NCAB Discusses Future of
Cancer Technology at NCI
"There is an extraordinary evolution going on in biomedical technology," said
Dr. Eric Lander, co-chair with Dr. Leland Hartwell of the National Cancer
Advisory Board (NCAB) ad hoc Subcommittee on Biomedical Technology Working
Group, as he began his presentation at the Board's meeting on September 14. Dr.
Lander discussed the Working Group's 2004 agenda, which focused on specific
ways to take advantage of the potential power of technology through projects,
initiatives, and structures that would have an effect all across cancer.
The
NCAB Biomedical Technology Subcommittee established the Working Group to advise
the Board, National Cancer Institute (NCI) Director Dr. Andrew C. von
Eschenbach, and senior leadership on the development and application of
biomedical technologies to cancer. Before this meeting, the Working Group
enlisted the help of outside experts and developed subgroups to examine
specific aspects and themes related to cancer and advancing technologies.
Read
more 
Communication: An Important
Cornerstone of Success
Last week NCI released its inaugural annual report, The Nation's Progress in Cancer Research for 2003, available at www.cancer.gov/aboutnci/annualreport. This new communication tool describes some of the successes from NCI-supported research published in late 2002 and 2003 - highlights that are representative of the discovery, development, and delivery continuum and illustrate the progress we are making toward the 2015 goal.
The development of an annual report is just one example of the evolution of how NCI communicates with its key constituencies, including the public. We have reached a crossroads in the battle against cancer, so it is vital that we communicate effectively with all of our stakeholders to provide evidence-based guidance and inform them about the latest happenings that affect their lives.
NCI's communication strategy is based on a two-pronged approach: first, we proactively disseminate information on current NCI initiatives, breaking cancer news, and other cancer topics. We are also prepared, however, to react and respond to scientific and programmatic issues as they arise.
Read
more
|
This NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads a national effort to eliminate the suffering and death due to cancer. Through basic and clinical biomedical research and training, NCI conducts and supports research that will lead to a future in which we can prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information on cancer,
call 1-800-4-CANCER or visit
http://cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
|
|
